“fulcrum-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32 11/05/19 San Diego
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further 09/23/19 Boston
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts 07/18/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away 09/07/18 National
Working with Patients and a Fresh $80M, Fulcrum Eyes a 2019 IPO 09/05/18 Boston
Inclusion in Labs, the C-Suite & More: Xconomy Awards Diversity Finalists 08/09/18 Boston
Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists 08/28/17 Boston
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Fulcrum Therapeutics Garners $55,000,000 Series A Funding 07/21/16 Boston
Page 1 of 1